Is rosiglitazone associated with increased risk for cardiovascular events?

被引：0
|
作者：
Markolf Hanefeld
机构：
[1] M Hanefeld is Professor of Internal Medicine and Director of the Centre for Clinical Studies at the Technical University in Dresden,
[2] Germany.,undefined
来源：
Nature Clinical Practice Cardiovascular Medicine | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 649
页数：1
相关论文
共 50 条
  • [41] Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes
    Corinna Niersmann
    Maren Carstensen-Kirberg
    Haifa Maalmi
    Bernd Holleczek
    Michael Roden
    Hermann Brenner
    Christian Herder
    Ben Schöttker
    Diabetologia, 2020, 63 : 410 - 418
  • [42] ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients
    Barnabas Gellen
    Nathalie Thorin-Trescases
    Philippe Sosner
    Elise Gand
    Pierre-Jean Saulnier
    Stéphanie Ragot
    Mathilde Fraty
    Stéphanie Laugier
    Grégory Ducrocq
    David Montaigne
    Pierre Llaty
    Vincent Rigalleau
    Philippe Zaoui
    Jean-Michel Halimi
    Ronan Roussel
    Eric Thorin
    Samy Hadjadj
    Diabetologia, 2016, 59 : 2321 - 2330
  • [43] Rosiglitazone and cardiovascular risk - Reply
    Psaty, Bruce M.
    Furberg, Curt D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09): : 940 - 940
  • [44] A High Cardiovascular Biomarker Panel Risk Score Is Associated with Increased 10-Year Risk of Cardiovascular Events and Death in SLE
    McMahon, Maureen A.
    Grossman, Jennifer M.
    Sahakian, Lori
    Charles-Schoeman, Christina
    Fitzgerald, John
    Taylor, Mihaela
    Gorn, Alan
    Olmos, Eloise
    Wallace, Daniel J.
    Hahn, Bevra H.
    Skaggs, Brian
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] INCREASED AORTIC STIFFNESS IS ASSOCIATED WITH INCREASED RISK FOR RECURRENT CARDIOVASCULAR EVENTS IN DIABETIC PATIENTS WITH ISCHEMIC HEART DISEASE
    Adamopoulou, E.
    Levisianou, D.
    Zairis, M.
    Triposkiadis, F.
    Melidonis, A.
    Foussas, S.
    JOURNAL OF HYPERTENSION, 2010, 28 : E292 - E292
  • [46] Aprotinin associated with increased renal dysfunction, but not with increased cerebrovascular or cardiovascular events
    不详
    FORMULARY, 2007, 42 (07) : 441 - 442
  • [47] Neutrophils and the increased risk of cardiovascular events in severe COPD
    Yazaki, Kenji
    Kamada, Naoko
    Fujibe, Yoshimi
    Kashima, Masayuki
    Asakura, Kenichi
    Sato, Mituko
    Sato, Tazuko
    Kikuchi, Kenji
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [48] Microscopic colitis: increased risk of major cardiovascular events
    Simon, Annika
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (05): : 694 - 695
  • [49] Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
    Baratta, Francesco
    Pastori, Daniele
    Angelico, Francesco
    Balla, Andrea
    Paganini, Alessandro Maria
    Cocomello, Nicholas
    Ferro, Domenico
    Violi, Francesco
    Sanyal, Arun J.
    Del Ben, Maria
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) : 2324 - +
  • [50] Heartbeat: hospitalisation for COVID-19 is associated with an increased risk of subsequent adverse cardiovascular events
    Otto, Catherine M.
    HEART, 2023, 109 (02) : 79 - 81
12345